AHA

This channel contains news about the American Heart Association (AHA), including coverage of its annual meeting and guidelines. AHA is a leading resource for cardiology information, both consumer and professional.

The AHA 2020 late-breaking SAMSON Trial found side effects reported from statins are real, but appear due to the psychological rather than the pharmacological effects of the cholesterol lowering drugs. #AHA20 #AHA2020

News | Pharmaceuticals

Side Effects Attributed to Statins Same for Those Taking a Placebo

November 16, 2020 — Among patients who stopped taking their cholesterol-lowering statin medication due to side effects ...

November 16, 2020

News | Pharmaceuticals

New Novartis Data for Inclisiran Shows Effective and Sustained LDL-C Reduction at 17 Regardless of Age or Gender

November 16, 2020 — Novartis announced results from two pooled post-hoc analyses of Phase III ORION-9, -10 and -11 ...

November 16, 2020

Feature | AHA | Dave Fornell, Editor

American Heart Association 2020 Late-breaking Trial Presentations

Here is a list of the American Heart Association (AHA) late-breaking clinical trial presentations at the 2020 Virtual ...

November 20, 2020

COVID-19 has a big impact on the heart, and patients with pre-existing cardiovascular disease have at least a 10 percent higher risk of death and severe complications due to the virus. The virus also can cause myocarditis, blood clotting, and impact the cardiovascular system due to severe, hyperactive inflammatory responses. Left, a cardiac CT scan 3-D rendering. right, the COVID-19 virus from a National Institutes of Health (NIH) photo.

Feature | Coronavirus (COVID-19)

AHA Explains Severe COVID-19 is Closely Associated With Heart Issues

August 17, 2020 - The number of people coronavirus disease 2019 (COVID-19) is rising with more cases in the U.S. There ...

August 17, 2020

The American Heart Association (AHA) has cancelled its in-person annual meeting due to COVID-19 and plans to host a virtual, online meeting instead.

News | AHA

AHA Annual Meeting Goes Virtual Due to COVID-19

July 15, 2020 – The last major cardiovascular conference to go virtual in 2020 due to the COVID-19 (SARS-Cov-2) pandemic ...

July 15, 2020

Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2

Feature | Cardiovascular Business

Societies Issue Guide to Safely Resume Cardiovascular Procedures and Tests

The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework ...

June 03, 2020

Feature | Coronavirus (COVID-19)

WHO Database Shows Serious Health Impact of Hydroxychloroquine and Azithromycin Being Used to Treat COVID-19

May 27, 2020 — Two of the front-line drugs being used to treat COVID-19 (SARS-CoV-2) patients are hydroxychloroquine and ...

May 27, 2020

Caution Recommended in use of COVID-19 Therapy Using Hydroxychloroquine and Azithromycin in Cardiovascular Disease Patients

Feature | Coronavirus (COVID-19)

AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients

April 8, 2020 – The scientific community is learning more about the impact and interaction of cardiovascular diseases ...

April 08, 2020

AHA, ACC, HRS, SCAI and other medical societies call for federal government to do what is needed to get medical supplies to front-line clinicians fighting COVID-19. #COVID19 #SARScov2 #Coronavirus

News | Coronavirus (COVID-19)

Healthcare Societies Issue Urgent Call for Federal Action to Address COVID-19 Medical Equipment Shortages

March 30, 2020 — A group of 13 U.S. medical societies sent an open letter to Congress appealing to them to do what is ...

March 30, 2020

News | Pharmaceuticals

Study Finds Drug Therapy for High Triglycerides to Have a Sustained Effect Using Low Dosages

December 30, 2019 — A drug therapy targeting the production of a protein produced by the liver has led to sustained and ...

December 30, 2019

The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital. Photo by Scott Morgan/AHA.

Feature

December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

December 17, 2019

News | AHA

Artificial Intelligence Examining ECGs Predicts Irregular Heartbeat, Death Risk

November 22, 2019 — Artificial intelligence can examine electrocardiogram (ECG) test results, a common medical test, to ...

November 22, 2019

News | AHA

Eko and Mayo Clinic Prove Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope

November 21, 2019 — At the American Heart Association Scientific Sessions 2019, Eko, a digital health company applying a ...

November 21, 2019

News | AHA

Weekend Sudden Cardiac Arrests are More Deadly

November 21, 2019 — People who experience cardiac arrests over the weekend are less likely to survive long enough to be ...

November 21, 2019

The Cordella Pulmonary Artery Pressure Sensor System for Heart failure. #AHA19 #AHA

News | Heart Failure

Positive Results for SIRONA First-in-Human Trial of the Cordella PA Pressure Sensor System

November 21, 2019 — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of ...

November 21, 2019